scholarly journals Economic evaluation of human papillomavirus vaccination in the United Kingdom

BMJ ◽  
2008 ◽  
Vol 337 (jul17 2) ◽  
pp. a769-a769 ◽  
Author(s):  
M. Jit ◽  
Y. H. Choi ◽  
W J. Edmunds
Keyword(s):  
United Kingdom ◽  
Human Papillomavirus ◽  
Economic Evaluation ◽  
Human Papillomavirus Vaccination ◽  
The United Kingdom

scholarly journals Human papillomavirus vaccination: the United Kingdom’s recommendation and update on European licensure and efficacy data

2007 ◽  
Vol 12 (46) ◽  
Author(s):  
R Howell-Jones
Keyword(s):  
United Kingdom ◽  
Human Papillomavirus ◽  
Vaccination Programme ◽  
Hpv Vaccination ◽  
Efficacy Data ◽  
Human Papillomavirus Vaccination ◽  
The United Kingdom ◽  
Catch Up

The United Kingdom (UK) has announced that it will introduce a Human papillomavirus (HPV) vaccination programme for all 12- to 13-year-old girls starting in 2008, and will implement a catch-up campaign for girls up to 18 years old.

Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom

Vaccine ◽  
2010 ◽  
Vol 28 (24) ◽  
pp. 4091-4102 ◽  
Author(s):  
Yoon Hong Choi ◽  
Mark Jit ◽  
Nigel Gay ◽  
Andrew Cox ◽  
Geoff P. Garnett ◽  
...  
Keyword(s):  
United Kingdom ◽  
Human Papillomavirus ◽  
Dynamic Modelling ◽  
Transmission Dynamic ◽  
Human Papillomavirus Vaccination ◽  
The United Kingdom ◽  
The Impact

Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom

Cancer ◽  
2002 ◽  
Vol 96 (1) ◽  
pp. 14-20 ◽  
Author(s):  
David R. Scott ◽  
Bjorn Hagmar ◽  
Peter Maddox ◽  
Anders Hjerpe ◽  
Joakim Dillner ◽  
...  
Keyword(s):  
United States ◽  
United Kingdom ◽  
Human Papillomavirus ◽  
The United States ◽  
Dna Testing ◽  
The United Kingdom ◽  
Papillomavirus Dna

A brief history of economic evaluation for human papillomavirus vaccination policy

Sexual Health ◽  
2010 ◽  
Vol 7 (3) ◽  
pp. 352 ◽  
Author(s):  
Philippe Beutels ◽  
Mark Jit
Keyword(s):  
Human Papillomavirus ◽  
Economic Evaluation ◽  
Policy Making ◽  
Cervical Screening ◽  
Hpv Vaccination ◽  
Health Economic Evaluation ◽  
Developed Countries ◽  
Economic Evaluations ◽  
Human Papillomavirus Vaccination ◽  
Screening Programs

Background: This commentary discusses key issues for health economic evaluation and modelling, applied to human papillomavirus (HPV) vaccine programs. Methods: We outline some of the specific features of HPV disease and vaccination, and associated policy questions in light of a literature search for economic evaluations on HPV vaccination. Results: We observe that some policy questions could not be reliably addressed by many of the 43 published economic evaluations we found. Despite this, policy making on universal HPV vaccination followed shortly after vaccine licensure in many developed countries, so the role economic evaluation played in informing these decisions (pre-dating 2008) seems to have been fairly limited. For more recent decisions, however, economic evaluation is likely to have been used more widely and more intensively. Conclusions: We expect future cost-effectiveness analyses to be more instrumental in policy making regarding vaccines covering more HPV types, therapeutic HPV vaccines, and novel diagnostic tests for biomarkers of HPV infection and disease integrated with cervical screening programs.

Economic Evaluation of Human Papillomavirus Vaccination in Developed Countries

2009 ◽  
Vol 12 (5-6) ◽  
pp. 343-351 ◽  
Author(s):  
Marc Brisson ◽  
Nicolas van de Velde ◽  
Marie-Claude Boily
Keyword(s):  
Human Papillomavirus ◽  
Economic Evaluation ◽  
Developed Countries ◽  
Human Papillomavirus Vaccination

scholarly journals Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom

2016 ◽  
Vol 12 (11) ◽  
pp. 2862-2871 ◽  
Author(s):  
Corinne Willame ◽  
Dominique Rosillon ◽  
Julia Zima ◽  
Maria-Genalin Angelo ◽  
Anke L. Stuurman ◽  
...  
Keyword(s):  
United Kingdom ◽  
Human Papillomavirus ◽  
Autoimmune Disease ◽  
Human Papillomavirus 16 ◽  
Adjuvanted Vaccine ◽  
The United Kingdom ◽  
New Onset

An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom

2011 ◽  
Vol 8 (1) ◽  
pp. 22-30 ◽  
Author(s):  
Dennis Getsios ◽  
Steve Blume ◽  
Khajak J. Ishak ◽  
Grant Maclaine ◽  
Luis Hernández
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
United Kingdom ◽  
Economic Evaluation ◽  
Early Assessment ◽  
The United Kingdom
Sign in / Sign up

Export Citation Format

Share Document